Rachelle Jacques

2023

In 2023, Rachelle Jacques earned a total compensation of $1.6M as Former President and Chief Executive Officer at Akari Therapeutics Plc, a 57% decrease compared to previous year.

Compensation breakdown

Option Awards$198,498
Salary$615,750
Stock Awards$729,393
Other$16,500
Total$1,560,141

Jacques received $729.4K in stock awards, accounting for 47% of the total pay in 2023.

Jacques also received $198.5K in option awards, $615.8K in salary and $16.5K in other compensation.

Rankings

In 2023, Rachelle Jacques' compensation ranked 741st out of 2,804 executives tracked by ExecPay. In other words, Jacques earned more than 73.6% of executives.

ClassificationRankingPercentile
All
741
out of 2,804
74th
Division
Manufacturing
432
out of 1,541
72nd
Major group
Chemicals And Allied Products
297
out of 871
66th
Industry group
Drugs
291
out of 834
65th
Industry
Pharmaceutical Preparations
193
out of 599
68th
Source: SEC filing on June 3, 2024.

Jacques' colleagues

We found two more compensation records of executives who worked with Rachelle Jacques at Akari Therapeutics Plc in 2023.

2023

Wendy DiCicco

Akari Therapeutics Plc

Chief Financial Officer

2023

Torsten Hombeck

Akari Therapeutics Plc

Chief Financial Officer

News

You may also like